Trump's nominee for the head of Indian Health Services is qualified for the position because he was a patient as a child, HHS says


President Trump has nominated Robert Weaver, 39, to head the Indian Health Service, citing his "nearly two decades of experience." But The Wall Street Journal is now raising questions about whether or not the Quapaw tribe member is actually qualified for the job. Of particular scrutiny is the time Weaver spent at St. John's Regional Medical Center in Joplin, Missouri, between 1997 and 2006, as he listed on the resume he gave to senators.
Weaver claims he had a financial role at the hospital and that he held "supervisory and management positions." Augusto Noronha, the chief financial officer at the hospital from 1999 to 2005, said: "I don't recall [Weaver's] name whatsoever." The director of patient financial services, Bob Henderson, said he did know the name Rob Weaver, and that the man had worked to register E.R. patients. When asked by the Journal if such a position was a leadership role, Henderson said: "Well, I guess it would depend upon how you look at leadership."
The hospital was unable to officially verify what Weaver's position was because of a 2011 tornado that damaged records. A Health and Human Services spokeswoman said Weaver's own employment records were destroyed in the same tornado.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"When asked by the Journal what constituted [Weaver's Indian Health Service] experience," The Wall Street Journal adds, "the spokeswoman said he had needed the system as a patient, especially when he was a child, and pointed to his career in health care." Read more about the questions surrounding Weaver's nomination to lead the agency responsible for the health care of more than 2 million Native Americans at The Wall Street Journal.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
How much does it cost to move? Here's how to budget and save.
the explainer Factors like move distance and the weight of your furnishings can affect the total cost — but there are several ways to economize
-
'The McDonald's menu board is one fascinating thing'
Instant Opinion Opinion, comment and editorials of the day
-
One great cookbook: 'Jam Bakes'
The Week Recommends A guide to pristine jam-making, plus the baked goods that love them
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC